# Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

> **NCT00318058** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 84 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** influenza vaccine Fluarix, Adjuvanted Fluarix

## Key facts

- **NCT ID:** NCT00318058
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10-03
- **Primary completion:** 2005-11-01
- **Final completion:** 2005-11-04
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318058, "Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00318058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*